Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
A Prospective Comparison of Transcriptional Profiling of Luteal Phase Endometrial Biopsies After Induction of Oocyte Maturation With a Gonadotropin Releasing Hormone (GnRH) Agonist or Human Chorionic Gonadotropins (hCG)
Sponsor: Schering-Plough
Terminated
Difficult to recruit patients
Listed as NCT01606709, this PHASE4 trial focuses on Endometrial Receptivity and Ovarian Hyperstimulation Syndrome and remains terminated or withdrawn. Sponsored by Schering-Plough, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 4 earlier versions
-
Dec 2018 — Jan 2021 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated · Phase: NA → PHASE4
-
Jun 2018 — Dec 2018 [monthly]
Unknown Status NA
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Schering-Plough
- UConn Health
For direct contact, visit the study record on ClinicalTrials.gov .